1. VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
- Author
-
Jiang Wei, Xia Liu, Wenfeng Ye, Yanhong Tang, Yan Lv, and Changfang Yao
- Subjects
0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,VEGF receptors ,Gastroenterology ,Group A ,Group B ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immunology and Microbiology (miscellaneous) ,Internal medicine ,Medicine ,Apgar score ,Neonatal weight ,Fetus ,biology ,business.industry ,Articles ,neonatal weight ,General Medicine ,VEGF ,Molecular medicine ,Vascular endothelial growth factor ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,embryonic structures ,biology.protein ,pregnancy induced hypertension syndrome ,sFLT-1 ,business - Abstract
The expression of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFLT-1) in the serum of patients with pregnancy induced hypertension (PIH) syndrome and its effects on the foetus was explored. A total of 105 cases of PIH pregnant women admitted to The First People's Hospital of Changzhou from March 2015 to February 2018 were divided into 3 groups according to the severity of the patients condition. Group A (n=35) was hypertension complicating pregnancy, group B (n=46) was mild preeclampsia and group C (n=24) was severe preeclampsia. In addition, 35 healthy pregnant women were selected as the control group. VEGF and sFLT-1 levels in serum were detected by enzyme linked immunosorbent assay, and the correlations between levels of VEGF and sFLT-1, neonatal weight and Apgar score were analyzed. Compared with group A, the level of serum VEGF was lower, while the level of sFLT-1 was higher in groups B and C (P
- Published
- 2019
- Full Text
- View/download PDF